We are live on
!
Find out more
CFO
Callan Family Office Portfolio holdings
AUM
$4.41B
1-Year Est. Return
26.21%
This Fund
S&P 500
This Quarter
Est. Return
+12.78%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.17B
AUM Growth
+$1.84B
(+138%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
50.05%
Top 10 Holdings %
Top 10 Hldgs %
25.88%
Holding
941
New
398
Increased
483
Reduced
23
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$74.8M |
| 2 |
NVIDIA
NVDA
|
+$66.1M |
| 3 |
Apple
AAPL
|
+$49.9M |
| 4 |
Amazon
AMZN
|
+$46.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$31.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$2.79M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$1.79M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.74M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$1.28M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 14.81% |
| 3 | Healthcare | 9.6% |
| 4 | Industrials | 7.93% |
| 5 | Communication Services | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
SES AI
SES
$208M
| $37.8K | ﹤0.01% |
+42,551
| New | +$35.7K |
|
902
Nautilus Biotechnolgy
NAUT
$115M
| $35.4K | ﹤0.01% |
+48,894
| New | +$36.7K |
|
|
BORR
903
Borr Drilling
BORR
$1.19B
| $34.6K | ﹤0.01% |
+18,918
| New | +$35.7K |
|
904
Actinium Pharmaceuticals
ATNM
$25M
| $33K | ﹤0.01% |
23,603
| – | – |
|
905
Wipro
WIT
$20B
| $32K | ﹤0.01% |
10,592
| – | – |
|
906
Transocean
RIG
$5.82B
| $29.8K | ﹤0.01% |
+11,502
| New | +$29.7K |
|
907
Maravai LifeSciences
MRVI
$919M
| $24.7K | ﹤0.01% |
+10,255
| New | +$21.6K |
|
|
IAUX
908
i-80 Gold Corp
IAUX
$1.4B
| $24.4K | ﹤0.01% |
+40,718
| New | +$24K |
|
|
HLVX
909
DELISTED
HilleVax
HLVX
| $23.4K | ﹤0.01% |
11,734
-7,593
| -39% | -$13.9K |
|
910
Energy Vault
NRGV
$633M
| $22.7K | ﹤0.01% |
+31,708
| New | +$25.6K |
|
911
Solid Power
SLDP
$532M
| $22.3K | ﹤0.01% |
+10,199
| New | +$14.3K |
|
|
GBIO
912
DELISTED
Generation Bio
GBIO
| $22.3K | ﹤0.01% |
+6,974
| New | +$26.9K |
|
913
Tenaya Therapeutics
TNYA
$163M
| $22.2K | ﹤0.01% |
36,269
-51,908
| -59% | -$26.4K |
|
914
Commercial Vehicle Group
CVGI
$147M
| $20.5K | ﹤0.01% |
+12,346
| New | +$15K |
|
915
Quantum-Si Incorporated
QSI
$177M
| $20.3K | ﹤0.01% |
+10,379
| New | +$15.4K |
|
916
W&T Offshore
WTI
$518M
| $18.7K | ﹤0.01% |
+11,340
| New | +$16.7K |
|
|
MRSN
917
DELISTED
Mersana Therapeutics
MRSN
| $16.7K | ﹤0.01% |
+2,262
| New | +$19.9K |
|
918
Wheels Up
UP
$198M
| $16.7K | ﹤0.01% |
+782
| New | +$19.2K |
|
919
Lightwave Logic
LWLG
$1.25B
| $16.5K | ﹤0.01% |
+13,283
| New | +$14K |
|
920
ChargePoint
CHPT
$161M
| $16.1K | ﹤0.01% |
+1,146
| New | +$15.4K |
|
921
Blink Charging
BLNK
$87.9M
| $15.8K | ﹤0.01% |
+16,779
| New | +$13.4K |
|
922
Standard BioTools
LAB
$314M
| $14.3K | ﹤0.01% |
+11,875
| New | +$13.2K |
|
923
374Water
SCWO
$37.6M
| $14.1K | ﹤0.01% |
+4,360
| New | +$14.7K |
|
|
AKYA
924
DELISTED
Akoya BioSciences
AKYA
| $13.6K | ﹤0.01% |
+10,465
| New | +$12.6K |
|
925
Harvard Bioscience
HBIO
$29.2M
| $13.2K | ﹤0.01% |
+2,984
| New | +$12.5K |
|
Similar funds
FIS
CAU
EQF
SFM
EC
IC
GIBU
Callan Family Office's Q2 2025 Portfolio in Review
As of Q2 2025, Callan Family Office held 941 positions worth $3.17B, up 138% from $1.33B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Callan Family Office deployed $1.59B of net new capital in Q2 2025, opening 398 new positions and adding to 483 existing holdings. Its largest new stake was Fortive: 72,724 shares worth $3.79M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $1.79M trimmed.
- Callan Family Office's largest Q2 2025 buy was Fortive: 72,724 shares worth $3.79M.
- Callan Family Office added most to Microsoft in Q2 2025, an estimated $74.8M increase.
- Callan Family Office's biggest Q2 2025 reduction was iShares Russell 1000 Value ETF, cutting an estimated $1.79M.
- Callan Family Office fully exited Discover Financial Services in Q2 2025, selling an estimated $2.79M.
- Callan Family Office's ten largest holdings make up 26% of its $3.17B portfolio in Q2 2025.
- Callan Family Office opened 398 new positions and closed 10 in Q2 2025.
- Callan Family Office's portfolio value rose 138% quarter-over-quarter to $3.17B.
Based on Callan Family Office's 13F filing for Q2 2025, filed 24 Jul 2025.